Thursday, October 28, 2010
Stunting tall men tied to lower testosterone
Stunting tall men tied to lower testosterone: "NEW YORK (Reuters Health) - Being tall may not seem like a big problem to most teen boys, but in Europe a few still choose to have their growth stunted by hormone injections.
"
Wednesday, October 27, 2010
PSA Test Reduces Risk of Spread if Prostate Cancer Strikes (HealthDay)
PSA Test Reduces Risk of Spread if Prostate Cancer Strikes
(HealthDay): "HealthDay - MONDAY, Oct. 25 (HealthDay News) -- Having a prostate-specific
antigen (PSA) test to screen for prostate cancer reduces the risk that if
cancer develops it will spread to other parts of the body, new research
indicates."
This article is saying that simply having a PSA test is a way of reducing the risk of prostate cancer spreading.
I assume that the author does not really believe that at all.
(HealthDay): "HealthDay - MONDAY, Oct. 25 (HealthDay News) -- Having a prostate-specific
antigen (PSA) test to screen for prostate cancer reduces the risk that if
cancer develops it will spread to other parts of the body, new research
indicates."
This article is saying that simply having a PSA test is a way of reducing the risk of prostate cancer spreading.
I assume that the author does not really believe that at all.
Tuesday, October 26, 2010
Low testosterone a problem in cancer: study
Low testosterone a problem in cancer: study: "NEW YORK (Reuters Health) - Aging men with cancer may be more plagued by low levels of testosterone than their tumor-free peers, U.S. researchers said Monday.
"
Aspirin may boost prostate cancer treatment: study
Aspirin may boost prostate cancer treatment: study: "WASHINGTON (Reuters) - Cheap, easy-to-take aspirin tablets may help men being treated for prostate cancer live longer, U.S. researchers reported on Monday.
Those who took the drugs had a 4 percent risk of dying from prostate cancer after 10 years, compared to 10 percent for men who did not take anticoagulants.
"
Those who took the drugs had a 4 percent risk of dying from prostate cancer after 10 years, compared to 10 percent for men who did not take anticoagulants.
Thursday, October 21, 2010
FDA orders new warnings on prostate cancer drugs
FDA orders new warnings on prostate cancer drugs: "WASHINGTON (Reuters) - Certain hormone treatments for prostate cancer must carry new warnings about an increased risk of diabetes and heart problems, the U.S. Food and Drug Administration said on Wednesday.
The medications include Abbott Laboratories Inc's Lupron, AstraZeneca Plc's Zoladex, Watson Pharmaceuticals Inc's Trelstar, and Sanofi-Aventis SA's Eligard.
"
The medications include Abbott Laboratories Inc's Lupron, AstraZeneca Plc's Zoladex, Watson Pharmaceuticals Inc's Trelstar, and Sanofi-Aventis SA's Eligard.
Baldness drug works, but some have sexual problems
Baldness drug works, but some have sexual problems: "NEW YORK (Reuters Health) - The widely used baldness drug finasteride (Propecia) indeed boosts hair growth in men, but some may develop sexual problems, according to a new analysis.
A review of recent research found that men with the most common form of baldness who took finasteride are more likely to experience an increase in hair count, and say they believe their hair is thicker. But approximately 1 in 80 also experience erectile dysfunction
"
A review of recent research found that men with the most common form of baldness who took finasteride are more likely to experience an increase in hair count, and say they believe their hair is thicker. But approximately 1 in 80 also experience erectile dysfunction
Wednesday, October 20, 2010
Men with prostate cancer at higher colon cancer risk: study (AFP)
Men with prostate cancer at higher colon cancer risk: study
(AFP): "
AFP - Men who have prostate cancer have a higher risk of developing colon cancer than men who don't have prostate cancer, US researchers said Tuesday.
Pomakov stressed the importance of men who have been diagnosed with prostate cancer having routine screening for colon cancer and called for larger studies to be done to determine if screening for colorectal cancer should begin earlier for prostate cancer patients than the currently recommended age of 50.
"
(AFP): "
Pomakov stressed the importance of men who have been diagnosed with prostate cancer having routine screening for colon cancer and called for larger studies to be done to determine if screening for colorectal cancer should begin earlier for prostate cancer patients than the currently recommended age of 50.
"
Subscribe to:
Posts (Atom)